The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer

Sandra L. Wong, Celia Chao, Michael J. Edwards, Diana Simpson, Kelly M. McMasters

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: Controversy exists regarding the routine use of cytokeratin immunohistochemistry (IHC) in the histopathologic examination of breast cancer sentinel lymph nodes (SLN) because the clinical significance of micrometastases detected by IHC is unclear. This analysis was performed to determine the frequency of IHC-detected micrometastases. Methods: All patients underwent SLN biopsy, followed by completion axillary dissection. This analysis included patients who had SLN evaluated by IHC. SLN were examined by hematoxylin and eosin (H&E) stain at 2-mm intervals, with IHC in 2 sections. The axillary dissection specimen was evaluated by routine H&E staining. Results: IHC was performed in SLNs from 973 patients. Of the 869 patients with negative nodes by H&E, 58 (6.7%) were "upstaged" by IHC. In 6 of 58 patients (10.3%) who had IHC-only positive SLN, nodal metastases were found in the axillary dissection specimen. Conclusions: IHC resulted in upstaging of 6.7% of patients who had negative SLN on H&E staining. These patients had a 10.3% risk of residual axillary nodal metastases. However, the clinical significance of IHC-only positive SLN requires further study.

Original languageEnglish (US)
Pages (from-to)330-334
Number of pages5
JournalAmerican Journal of Surgery
Volume182
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Sentinel Lymph Node Biopsy
Keratins
Immunohistochemistry
Staining and Labeling
Breast Neoplasms
Dissection
Neoplasm Micrometastasis
Neoplasm Metastasis
Hematoxylin
Eosine Yellowish-(YS)
Sentinel Lymph Node
Coloring Agents

Keywords

  • Breast cancer
  • Cytokeratin
  • Immunohistochemistry
  • Micrometastasis
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Surgery

Cite this

The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. / Wong, Sandra L.; Chao, Celia; Edwards, Michael J.; Simpson, Diana; McMasters, Kelly M.

In: American Journal of Surgery, Vol. 182, No. 4, 2001, p. 330-334.

Research output: Contribution to journalArticle

Wong, Sandra L. ; Chao, Celia ; Edwards, Michael J. ; Simpson, Diana ; McMasters, Kelly M. / The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. In: American Journal of Surgery. 2001 ; Vol. 182, No. 4. pp. 330-334.
@article{db9e4a6b3baa4ff1870f070325a3b56d,
title = "The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer",
abstract = "Background: Controversy exists regarding the routine use of cytokeratin immunohistochemistry (IHC) in the histopathologic examination of breast cancer sentinel lymph nodes (SLN) because the clinical significance of micrometastases detected by IHC is unclear. This analysis was performed to determine the frequency of IHC-detected micrometastases. Methods: All patients underwent SLN biopsy, followed by completion axillary dissection. This analysis included patients who had SLN evaluated by IHC. SLN were examined by hematoxylin and eosin (H&E) stain at 2-mm intervals, with IHC in 2 sections. The axillary dissection specimen was evaluated by routine H&E staining. Results: IHC was performed in SLNs from 973 patients. Of the 869 patients with negative nodes by H&E, 58 (6.7{\%}) were {"}upstaged{"} by IHC. In 6 of 58 patients (10.3{\%}) who had IHC-only positive SLN, nodal metastases were found in the axillary dissection specimen. Conclusions: IHC resulted in upstaging of 6.7{\%} of patients who had negative SLN on H&E staining. These patients had a 10.3{\%} risk of residual axillary nodal metastases. However, the clinical significance of IHC-only positive SLN requires further study.",
keywords = "Breast cancer, Cytokeratin, Immunohistochemistry, Micrometastasis, Sentinel lymph node biopsy",
author = "Wong, {Sandra L.} and Celia Chao and Edwards, {Michael J.} and Diana Simpson and McMasters, {Kelly M.}",
year = "2001",
doi = "10.1016/S0002-9610(01)00722-X",
language = "English (US)",
volume = "182",
pages = "330--334",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer

AU - Wong, Sandra L.

AU - Chao, Celia

AU - Edwards, Michael J.

AU - Simpson, Diana

AU - McMasters, Kelly M.

PY - 2001

Y1 - 2001

N2 - Background: Controversy exists regarding the routine use of cytokeratin immunohistochemistry (IHC) in the histopathologic examination of breast cancer sentinel lymph nodes (SLN) because the clinical significance of micrometastases detected by IHC is unclear. This analysis was performed to determine the frequency of IHC-detected micrometastases. Methods: All patients underwent SLN biopsy, followed by completion axillary dissection. This analysis included patients who had SLN evaluated by IHC. SLN were examined by hematoxylin and eosin (H&E) stain at 2-mm intervals, with IHC in 2 sections. The axillary dissection specimen was evaluated by routine H&E staining. Results: IHC was performed in SLNs from 973 patients. Of the 869 patients with negative nodes by H&E, 58 (6.7%) were "upstaged" by IHC. In 6 of 58 patients (10.3%) who had IHC-only positive SLN, nodal metastases were found in the axillary dissection specimen. Conclusions: IHC resulted in upstaging of 6.7% of patients who had negative SLN on H&E staining. These patients had a 10.3% risk of residual axillary nodal metastases. However, the clinical significance of IHC-only positive SLN requires further study.

AB - Background: Controversy exists regarding the routine use of cytokeratin immunohistochemistry (IHC) in the histopathologic examination of breast cancer sentinel lymph nodes (SLN) because the clinical significance of micrometastases detected by IHC is unclear. This analysis was performed to determine the frequency of IHC-detected micrometastases. Methods: All patients underwent SLN biopsy, followed by completion axillary dissection. This analysis included patients who had SLN evaluated by IHC. SLN were examined by hematoxylin and eosin (H&E) stain at 2-mm intervals, with IHC in 2 sections. The axillary dissection specimen was evaluated by routine H&E staining. Results: IHC was performed in SLNs from 973 patients. Of the 869 patients with negative nodes by H&E, 58 (6.7%) were "upstaged" by IHC. In 6 of 58 patients (10.3%) who had IHC-only positive SLN, nodal metastases were found in the axillary dissection specimen. Conclusions: IHC resulted in upstaging of 6.7% of patients who had negative SLN on H&E staining. These patients had a 10.3% risk of residual axillary nodal metastases. However, the clinical significance of IHC-only positive SLN requires further study.

KW - Breast cancer

KW - Cytokeratin

KW - Immunohistochemistry

KW - Micrometastasis

KW - Sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=0035166886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035166886&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(01)00722-X

DO - 10.1016/S0002-9610(01)00722-X

M3 - Article

VL - 182

SP - 330

EP - 334

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -